tirzepatide stomach issues After Gastric Sleeve: Safety and Clinical Guidance Tirzepatide Side Effects: Common &

10.1038/s41419-020-2298-2 96 LiL.QiuC.HouM.WangX.HuangC.ZouJ.et al (2021)

In the SELECT study, people taking Wegovy had about 20% fewer heart-related events (meaning roughly 2 fewer events for every 10 that would have occurred otherwise)

Wegovy pill may be worth discussing with your provider if you: Meet the BMI criteria for treatment Injection anxiety has been a barrier to trying GLP-1 medications A daily routine with a 30-minute fasting window sounds doable Room-temperature storage appeals to you more than refrigeration If youre already using injectable GLP-1 medications like compounded semaglutide or compounded tirzepatide through Ivms GLP-1 ID program and seeing good results, there may not be a clinical reason to switch

Eligibility, continuation, or discontinuation of GLP1 treatment is determined independently by licensed clinicians based on medical evaluation, not by celebrity outcomes or platform access

The authors noted its potential for treating various conditions while also highlighting the need for more long-term safety research

We know that for these patients with obesity, diabetes, CKD, cardiovascular disease [CVD], these are really not isolated or distinct entities. However, the research comes at a time when supply chain issues for the GLP-1 receptor agonists have been pronounced and prolonged